Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fiscal 1990 budget agreement

Executive Summary

Budget bill unanimously adopted by a House/Senate conference committee on May 11 includes $ 100 mil. in "unspecified savings" in health program. Staffers say the line item, adopted from the Senate version, was inspired by the Bush Administration's FDA user fee proposal. However, they note, the savings are "assumed" but not "forced" upon the authorization or appropriations committees. Leaders of both the Senate Labor & Human Resources Committee and the House Energy & Commerce Committee -- including Sens. Kennedy (D-Mass.) and Hatch (R-Utah), and Rep. Waxman (D-Calif.) -- oppose FDA user fees. The budget plan must be approved by the full House and Senate.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS015593

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel